Page last updated: 2024-11-01

norfloxacin and Hemolysis

norfloxacin has been researched along with Hemolysis in 7 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Chugunova, E1
Akylbekov, N1
Bulatova, A1
Gavrilov, N1
Voloshina, A1
Kulik, N1
Zobov, V1
Dobrynin, A1
Syakaev, V1
Burilov, A1
Lin, S1
Koh, JJ1
Aung, TT1
Sin, WLW1
Lim, F1
Wang, L1
Lakshminarayanan, R1
Zhou, L1
Tan, DTH1
Cao, D1
Beuerman, RW1
Ren, L1
Liu, S1
Zhang, E1
Bai, PY1
Cui, DY1
Chu, WC1
Hua, YG1
Liu, Q1
Yin, HY1
Zhang, YJ1
Qin, S1
Liu, HM1
Niu, Y1
Wang, M1
Cao, Y1
Nimmagadda, A1
Hu, J1
Wu, Y1
Cai, J1
Ye, XS1
Zhang, PL1
Gopala, L1
Zhang, SL1
Cai, GX2
Zhou, CH2
Sun, H1
Huang, SY1
Jeyakkumar, P1
Fang, B1
Ferguson, J1
Johnson, BE1

Trials

1 trial available for norfloxacin and Hemolysis

ArticleYear
Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic.
    The British journal of dermatology, 1993, Volume: 128, Issue:3

    Topics: Adolescent; Adult; Candida albicans; DNA; Dose-Response Relationship, Drug; Double-Blind Method; Fem

1993

Other Studies

6 other studies available for norfloxacin and Hemolysis

ArticleYear
Synthesis and biological evaluation of novel structural hybrids of benzofuroxan derivatives and fluoroquinolones.
    European journal of medicinal chemistry, 2016, Jun-30, Volume: 116

    Topics: Anti-Bacterial Agents; Bacteria; Benzoxazoles; Chemistry Techniques, Synthetic; Drug Design; Fluoroq

2016
Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).
    Journal of medicinal chemistry, 2017, 07-27, Volume: 60, Issue:14

    Topics: Animals; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; C

2017
Synthesis and bioactivities study of new antibacterial peptide mimics: The dialkyl cationic amphiphiles.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Alkylation; Anti-Bacterial Agents; Bacteria; Biofilms; Cell Membrane Permeability; Chemistry Techniq

2018
Rational Design of Dimeric Lysine N-Alkylamides as Potent and Broad-Spectrum Antibacterial Agents.
    Journal of medicinal chemistry, 2018, 04-12, Volume: 61, Issue:7

    Topics: Amides; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Drug Design; Drug Resistance, M

2018
An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
    European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

    Topics: Allosteric Regulation; Allosteric Site; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Dr

2022
Natural Berberine-derived Azolyl Ethanols as New Structural Antibacterial Agents against Drug-Resistant
    Journal of medicinal chemistry, 2022, 01-13, Volume: 65, Issue:1

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Berberine; Biofilms; DNA, Bacterial; Drug Resistance,

2022